Vantictumab (Anti-FZD)
Product Specifications
CAS Number
1345009-45-1
Synonyms
OMP-18R5
SKU
C00288-1mg
Target
Wnt/beta-catenin
Applications
Cytoskeletal Signaling
Additionnal Information
Vantictumab (Anti-FZD) is a monoclonal antibody targeting the Wnt signaling pathway with potential antineoplastic activity. Vantictumab binds to certain receptors in the Wnt signaling pathway thereby preventing the activation of the Wnt signaling pathway. This results in an inhibition of cancer stem cell (CSC) activity and a subsequent inhibition of cancer cell proliferation. MW: 145.5 KD.
Storage Conditions
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
PKSM041055-01 10 µg
Recombinant Mouse IL-23 Receptor/IL-23R Protein (Fc Tag)
Sign In for Pricing
View Details PKSM041055-02 50 µg
Recombinant Mouse IL-23 Receptor/IL-23R Protein (Fc Tag)
Sign In for Pricing
View Details 
GP-2201-40 1 mL
Colloidal Gold Conjugated Ulex europaeus Lectin (Gorse, Furze) -UEA-I-, 1mL 40nm
Sign In for Pricing
View Details ![[2,2'-Bis(diphenylphosphino)-1,1'-binaphthalene]chloro(p-cymene)ruthenium Chloride](https://cdn.genprice.uk/products/572/2825588418139/imageurl/trc-b430395-500mg.webp)
TRC-B430395-500MG 500 mg
[2,2'-Bis(diphenylphosphino)-1,1'-binaphthalene]chloro(p-cymene)ruthenium Chloride
Sign In for Pricing
View Details